Barinthus Biotherapeutics PLC
NASDAQ:BRNS

Watchlist Manager
Barinthus Biotherapeutics PLC Logo
Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Watchlist
Price: 0.7204 USD 2.33% Market Closed
Market Cap: 29.4m USD

Wall Street
Price Targets

BRNS Price Targets Summary
Barinthus Biotherapeutics PLC

Wall Street analysts forecast BRNS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRNS is 5.1 USD with a low forecast of 3.03 USD and a high forecast of 7.35 USD.

Lowest
Price Target
3.03 USD
321% Upside
Average
Price Target
5.1 USD
608% Upside
Highest
Price Target
7.35 USD
920% Upside
Barinthus Biotherapeutics PLC Competitors:
Price Targets
TGTX
TG Therapeutics Inc
41% Upside
PHM
Pharma Mar SA
32% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
31% Upside
KURA
Kura Oncology Inc
222% Upside
ELIC
Elicera Therapeutics AB
46% Upside
PGEN
Precigen Inc
140% Upside
688331
RemeGen Co Ltd
6% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
9% Upside

Revenue
Forecast

Revenue Estimate
Barinthus Biotherapeutics PLC

For the last 4 years the compound annual growth rate for Barinthus Biotherapeutics PLC's revenue is 33%.

33%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Barinthus Biotherapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Barinthus Biotherapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BRNS's stock price target?
Price Target
5.1 USD

According to Wall Street analysts, the average 1-year price target for BRNS is 5.1 USD with a low forecast of 3.03 USD and a high forecast of 7.35 USD.

Back to Top